$27.15 0.00 (%) Acadia Pharmaceuticals Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. On The Fly: After Hours Movers - 11/8

    TalkMarkets | Nov. 8, 2016 | 02:44AM EST
  2. Why Are Analysts So Bullish On This Tumbling Biotech Company?

    Benzinga | Feb. 8, 2016 | 10:32AM EST
  3. Benzinga's Top Initiations

    Benzinga | Feb. 8, 2016 | 09:50AM EST
  4. Acadia Pharmaceuticals Are Spiking

    Benzinga | Feb. 1, 2016 | 08:55AM EST
  5. Benzinga's Top Upgrades

    Benzinga | Jan. 22, 2016 | 08:50AM EST
  6. Here's Why There's Been A Rush Of Biotech Offerings

    Benzinga | Jan. 7, 2016 | 11:32AM EST
  7. ACADIA Pharmaceuticals Prices ~10.344M Share Offering @$29.00/Share

    Benzinga | Jan. 7, 2016 | 04:12AM EST
  8. ACADIA Pharmaceuticals Appoints Srdjan (Serge) Stankovic, M.D., M.S.P.H., as EVP, Head of Research and Development

    Benzinga | Nov. 30, 2015 | 09:02AM EST
  9. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga | Sep. 14, 2015 | 15:01PM EST
  10. Morning Market Gainers

    Benzinga | Sep. 3, 2015 | 08:42AM EST
  11. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 3, 2015 | 07:14AM EST
  12. Why Piper Jaffray Is Upgrading Acadia Pharmaceuticals After A 25% Decline

    Benzinga | Aug. 27, 2015 | 14:06PM EST
  13. Acadia Pharma May No Longer Be A Buy Ahead Of NDA Filing

    Benzinga | Aug. 7, 2015 | 12:27PM EST
  14. Stocks Easing Off Day's Lows; Caesarstone Rebounds

    IBD | Aug. 7, 2015 | 12:00PM EST
  15. Andreas Halvorsen Increases Stake in Esperion Therapeutics

    GuruFocus | Jun. 29, 2015 | 23:18PM EST
  16. Viking Global Liked AIG, Google, Actavis, Illumina And Cheniere Energy Last Quarter

    Benzinga | May. 18, 2015 | 12:38PM EST
  17. Benzinga's Top Initiations

    Benzinga | Apr. 16, 2015 | 08:45AM EST
  18. Acadia Will Outperform, Worth $48/Share Says Leerink

    Benzinga | Apr. 16, 2015 | 08:39AM EST
  19. Leerink Swann Initiates ACADIA Pharmaceuticals At Outperform

    Benzinga | Apr. 16, 2015 | 07:26AM EST
  20. Cowen Analyst Likes Intercept Pharmaceuticals, ACADIA Pharmaceuticals And Raptor Pharmaceutical

    Benzinga | Feb. 1, 2015 | 12:54PM EST
  21. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  22. Benzinga's Top Initiations

    Benzinga | Nov. 21, 2014 | 08:21AM EST
  23. Earnings Scheduled For November 10, 2014

    Benzinga | Nov. 10, 2014 | 05:36AM EST
  24. Benzinga's Volume Movers

    Benzinga | Sep. 2, 2014 | 09:25AM EST
  25. ACADIA Pharmaceuticals Announces Stephen Davis As Executive VP, CFO And Chief Business Officer

    Benzinga | Jul. 15, 2014 | 08:01AM EST
  26. 4 Biotech Stocks Worth A Look Ahead Of FDA Approvals

    Benzinga | Jul. 3, 2014 | 09:36AM EST
  27. Morning Lowers for Mar. 5, 2014: XOMA, USU, CSIQ, AUDC, RATE

    Benzinga | Mar. 5, 2014 | 10:14AM EST
  28. Top Stocks Of 2013 Run Gamut: Solar, Drugs, Tech, TV

    IBD | Jan. 2, 2014 | 18:59PM EST
  29. ACADIA Initiates Phase II Trial with Pimavanserin for Alzheimer's Disease Psychosis

    Benzinga | Nov. 14, 2013 | 09:19AM EST
  30. ACADIA Announces Publication of Pivotal Phase III Parkinson's Disease Psychosis Trial with Pimavanserin

    Benzinga | Nov. 1, 2013 | 05:01AM EST
  31. Benzinga's Volume Movers

    Benzinga | Oct. 10, 2013 | 09:33AM EST
  32. Benzinga's Top Pre-Market Gainers

    Benzinga | Oct. 10, 2013 | 07:16AM EST
  33. UPDATE: MLV & Co. Downgrades ACADIA Pharmaceuticals on Valuation

    Benzinga | Aug. 7, 2013 | 07:56AM EST
  34. Benzinga's Top Downgrades

    Benzinga | Aug. 7, 2013 | 06:45AM EST
  35. Acadia Pharma Announces $86M Equity Financing

    Benzinga | Dec. 12, 2012 | 02:05AM EST
  36. Benzinga's Top Pre-Market Losers

    Benzinga | Nov. 28, 2012 | 01:16AM EST
  37. ACADIA Pharmaceuticals Option Volume Spikes

    SchaeffersResearch | Nov. 27, 2012 | 10:36AM EST
  38. Acadia Pharma Rockets Higher on Study Results

    Benzinga | Nov. 27, 2012 | 09:44AM EST
  39. Top Narrow Based Indexes For November 27, 2012

    Benzinga | Nov. 27, 2012 | 03:38AM EST
  40. Stocks Hitting 52-Week Highs

    Benzinga | Nov. 27, 2012 | 03:06AM EST
  41. Morning Market Movers

    Benzinga | Nov. 27, 2012 | 02:49AM EST
  42. Benzinga's Top Pre-Market Gainers

    Benzinga | Nov. 27, 2012 | 01:13AM EST
  43. ACADIA's Pimavanserin Meets Primary and Key Secondary Endpoints in Pivotal Phase III Parkinson's Disease Psychosis Trial

    Benzinga | Nov. 27, 2012 | 00:27AM EST
  44. ACADIA Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 5, 2012 | 11:11AM EST
  45. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 19, 2012 | 03:23AM EST
  46. Benzinga's Top Pre-Market Gainers

    Benzinga | Sep. 17, 2012 | 01:14AM EST
  47. Coinstar, Supervalu Among Stocks Down on Above-average Volume Friday

    FoxBusiness | Jul. 13, 2012 | 05:31AM EST
  48. From Earlier, ACADIA Pharmaceuticals Reports Promising Effects of Pimavanserin in Preclinical Model of Alzheimer's Disease Psychosis

    Benzinga | Jul. 9, 2012 | 02:21AM EST
  49. Earnings Scheduled For March 6

    Benzinga | Mar. 5, 2012 | 20:58PM EST
Trading Center